SINOVAC: Supply Vaccines to Eliminate Human Diseases

News & Events

2024/12/16

SINOVAC Initiated a Phase Ⅲ Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)

The first phase III clinical trial on a multivalent HFMD vaccine in the worldDecember 13, 2024, Beijing, China – Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a

Hepatitis A Prevention and Control Technology and Vaccination Conference Held in Beijing

On July 20, 2024, Sinovac Biotech Ltd. ("SINOVAC" or the "Company") and the China Foundation for Hepatitis Prevention and Control successfully jointly held the "Hepatitis A Pr

2024/07/29
SINOVAC's Varicella Vaccine was Approved by China National Medical Products Administration (NMPA) for Use in Adolescents and Adults Aged 13 Years Old and Above

Beijing, China – June 18, 2024 – Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that its PROV

2024/06/18
SINOVAC Made Major Announcements Today

On June 4, 2024, Vice-President of Brazil and Minister for Development, Industry and Trade Geraldo Alckmin met with Mr. Yin Weidong, Chairman, President, and CEO of SINOVAC, in Beijing, China. Vice-Pr

2024/06/05

R&D and Innovation

SINOVAC has undertaken nearly 60 national and regional science and technology
R&D projects; received two State Scientific and Technology Progress Awards
and three national-level institutional technology awards; and published more than
140 SCI papers, many of which were published in top academic journals including
New England Journal of Medicine, The Lancet, Science and Nature, etc.

Our Vaccines

SINOVAC approved products include: COVID-19 Vaccine (Vero Cell), Inactivated - CoronaVac®, Enterovirus Type 71 Vaccine (Vero cell), Inactivated - Inlive®, Hepatitis A Vaccine (Human Diploid Cell) Inactivated - Healive®, Influenza Vaccine (Split Virion), Inactivated - Anflu®, 23-valent Pneumococcal Polysaccharide Vaccine, Varicella Vaccine(Live), Mumps Vaccine(Live), etc.

COVID-19 Vaccine (Vero Cell), Inactivated - CoronaVac^®

Validated by the World Health Organization's Emergency Use Listing ("EUL") Procedure on June 2, 2021

Enterovirus Type 71 Vaccine (Vero cell), Inactivated - Inlive^®

Validated by the World Health Organization's Emergency Use Listing ("EUL") Procedure on June 2, 2021

Hepatitis A Vaccine (Human Diploid Cell), Inactivated - Healive^®

Launched in 2002.

Influenza Vaccine Product Family

Influenza Vaccine (Split Virion), Inactivated, Quadrivalent. Influenza Vaccine (Split Virion), Inactivated - Anflu^®. Pandemic Influenza Vaccine (Inactivated, Adjuvanted) - Panflu^®. H1N1 Influenza A Vaccine (Split Virion), Inactivated - Panflu.1^®.